VentriPoint Diagnostics (TSXV:VPT) 3-Year EBITDA Growth Rate : 13.60% (As of Sep. 2023)

View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics 3-Year EBITDA Growth Rate?

VentriPoint Diagnostics's EBITDA per Share for the three months ended in Sep. 2023 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of VentriPoint Diagnostics was 49.80% per year. The lowest was -129.00% per year. And the median was 13.60% per year.

Competitive Comparison of VentriPoint Diagnostics's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, VentriPoint Diagnostics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VentriPoint Diagnostics's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's 3-Year EBITDA Growth Rate falls into.

VentriPoint Diagnostics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

VentriPoint Diagnostics (TSXV:VPT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

VentriPoint Diagnostics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

VentriPoint Diagnostics (TSXV:VPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

VPTDF:USA 5V7:Germany

Address

18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4

Website

https://www.ventripoint.com

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

Executives

Robert Hodgkinson

Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines